Gene Therapy for the Treatment of Cancer

作者: H. Trent Spencer , Jacques Galipeau

DOI: 10.1007/978-1-59259-734-5_27

关键词:

摘要: Since the initial confirmation that genetic alterations cause disease, pervasive outlook has been future for gene therapy is very promising, but curing diseases by transfer of specific nucleic acid sequences problematic. It should be recognized, however, hurdles facing investigators in field can defined and are likely not insurmountable. The major limitations inability to genetically modify sufficient numbers target cells express transferred gene(s) over prolonged periods (1,2). With respect application treatment cancer, many aspects fundamental these different than those faced pioneers other treatments, example, development chemotherapy agents, which mainly a lack understanding biological systems being manipulated. Even so, great strides accomplishments have achieved during last decade, only with physical genes into also clinical practice (3). purpose this chapter provide general background on how as well example focusing translation study from inception through completed Phase III trial.

参考文章(104)
Scott M. Freeman, Suicide gene therapy. Advances in Experimental Medicine and Biology. ,vol. 465, pp. 411- 422 ,(2002) , 10.1007/0-306-46817-4_36
Gary L. Buchschacher, Flossie Wong-Staal, Development of lentiviral vectors for gene therapy for human diseases Blood. ,vol. 95, pp. 2499- 2504 ,(2000) , 10.1182/BLOOD.V95.8.2499
M Gräble, P Hearing, cis and trans requirements for the selective packaging of adenovirus type 5 DNA. Journal of Virology. ,vol. 66, pp. 723- 731 ,(1992) , 10.1128/JVI.66.2.723-731.1992
R. G. Vile, Heung Chong, I. R. Hart, J. A. Nelson, S. Castleden, Systemic Gene Therapy of Murine Melanoma Using Tissue Specific Expression of the HSVtk Gene Involves an Immune Component Cancer Research. ,vol. 54, pp. 6228- 6234 ,(1994)
G B Elion, R L Miller, J A Fyfe, P A Furman, P M Keller, Thymidine kinase from herpes simplex virus phosphorylates the new antiviral compound, 9-(2-hydroxyethoxymethyl)guanine. Journal of Biological Chemistry. ,vol. 253, pp. 8721- 8727 ,(1978) , 10.1016/S0021-9258(17)34236-9
Lucia Magnelli, Mark A. Israel, Vincenzo P. Chiarugi, Wolfgang Hamel, Herpes Simplex Virus Thymidine Kinase/Ganciclovir-mediated Apoptotic Death of Bystander Cells Cancer Research. ,vol. 56, pp. 2697- 2702 ,(1996)
Meredith Wadman, NIH under fire over gene-therapy trials. Nature. ,vol. 403, pp. 237- 237 ,(2000) , 10.1038/35002176
F L Cosset, Y Takeuchi, J L Battini, R A Weiss, M K Collins, High-titer packaging cells producing recombinant retroviruses resistant to human serum. Journal of Virology. ,vol. 69, pp. 7430- 7436 ,(1995) , 10.1128/JVI.69.12.7430-7436.1995
I Mottet, Jean Pierre Brion, Roger Demeure, Jean Noël Octave, A Maron, A Le Roux, J F Dedieu, M Perricaudet, T Gustin, Gene therapy of rat C6 glioma using adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene: long-term follow-up by magnetic resonance imaging. Gene Therapy. ,vol. 3, pp. 315- 322 ,(1996)